Evaluation of the Number of Fragments of Parathyroid Gland Tissue that are Used in Patients Who Have Been Submitted to Total Removal of the Parathyroid Glands in the Treatment of Hyperparathyroidism Due to the Loss of the Renal Function.
Not Applicable
Recruiting
- Conditions
- E21.1Cronic kidney disease, secondary hyperparathyroidism, parathyroidectomy
- Registration Number
- RBR-785wvb
- Lead Sponsor
- niversidade Federal de São Paulo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with end-stage renal kidney disease on hemodialysis; hypercalcemia or hyperphosphatemia;
pruritus; bone pain , bone deformity or fracture, extra-osseus calcification, between 18 and 60 years
Exclusion Criteria
Patients subjected to renal transplantation
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increased in the PTH level verified by means of serum dosages in the postoperative period, based on their adjustment to the parameters suggested by the international consensus of KDOQI and KDIGO
- Secondary Outcome Measures
Name Time Method Decrease in the amount of medication verified by the reduction in the amount in grams per day needed to maintain calcemia